Tadalafil C-20 20 mg/tab – US Stock

Tadalafil C-20 20 mg/tab from Hilma Biocare is an oral tablet formulation containing tadalafil, a phosphodiesterase type 5 (PDE5) inhibitor. Each tablet contains 20 mg of active ingredient, and the product is supplied in a 10-tablet pack.

Product Overview

Tadalafil is a long-acting PDE5 inhibitor. The supplied product information identifies an active half-life of approximately 17 hours and describes tadalafil in connection with blood-flow and vascular effects.

The product is supplied as an oral tablet and is specified as having no water retention or aromatization.

Active Ingredient

The active ingredient is Tadalafil, identified in the product specifications as Tadalafil C-20.

Dosage Form and Strength

Tadalafil C-20 is supplied as an oral tablet containing 20 mg of tadalafil per tablet.

Product Characteristics

According to the supplied specifications, Tadalafil C-20 has the following characteristics:

• Oral/tablet formulation
• 20 mg tadalafil per tablet
• Approximately 17-hour active half-life
• PDE5 inhibitor classification
• No water retention listed
• No aromatization listed
• 10 tablets per pack

Product Specifications

Product Characteristics

Tadalafil belongs to the PDE5 inhibitor class and is described in the supplied information as having a longer active half-life than some other compounds in the same category. The source material associates tadalafil with sexual function and vascular blood-flow effects.

The supplied description also discusses use by athletes and bodybuilders in relation to circulation, stamina, and training. These performance-related descriptions are source-based and should not be interpreted as established medical indications or guarantees of athletic outcomes.

Reported Side Effects

The supplied product information lists several possible adverse effects, including:

• Headache
• Nasal congestion
• Facial redness
• Lowered blood pressure

Tadalafil can affect vascular function and blood pressure. Individuals should consult an appropriately qualified healthcare professional regarding contraindications, potential interactions, and suitability before use.

Important Information

Tadalafil is a pharmacologically active PDE5 inhibitor. The information on this page is provided for product identification and factual specification purposes only and does not constitute personalized medical advice.

No dosing recommendations, treatment protocols, or instructions for self-administration are provided. The supplied information specifically states that Tadalafil C-20 should not be combined with other PDE5 inhibitors; potential interactions with other medicines or compounds should be evaluated by a healthcare professional.

About Hilma Biocare USA

Tadalafil C-20 20 mg/tab is part of the Hilma Biocare product range. Each tablet contains 20 mg of tadalafil, and the product is supplied in a 10-tablet pack as US Stock.